The role of external beam radiation therapy in well-differentiated thyroid cancer

References

• Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29.
   PubMed Web of Science ®Google Scholar
• Sherman SI. Thyroid carcinoma. Lancet. 2003;361(9356):501–511.
   PubMed Web of Science ®Google Scholar
• Brito JP, Davies L. Is there really an increased incidence of thyroid cancer? Curr Opin Endocrinol Diabetes Obes. 2014;21(5):405–408.
   PubMed Web of Science ®Google Scholar
• Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014;140(4):317–322.
   PubMed Web of Science ®Google Scholar
• Vaccarella S, Franceschi S, Bray F. Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis. N Engl J Med. 2016;375(7):612–614.
   PubMed Web of Science ®Google Scholar
• Statistics Canada. Cancer incidence in Canada, 2007 and 2008. [Internet] Ottawa, On: Minister of Industry, 2010 [Statistics Canada, Catlogue no.:82-231-X].
   Google Scholar
• Ahn HS, Kim HJ, Welch HG. Korea’s thyroid-cancer “epidemic” — screening and overdiagnosis. N Engl J Med. 2010;363(1):1763–1765.
   PubMed Web of Science ®Google Scholar
• Gilliland FD, Hunt WC, Morris DM, et al. Prognostic factors for thyroid carcinoma: a population-based study of 15,698 cases from the Surveillance, Epidemiology, and End Results (SEER) Program 1973 –1991. Cancer. 1997;79(3):564–573.
   PubMed Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.
   PubMed Web of Science ®Google Scholar
• Tubiana M, Haddad E, Schlumberger M, et al. External radiotherapy in thyroid cancers. Cancer. 1985;55(9 Suppl):2062–2071.
   PubMed Web of Science ®Google Scholar
• Biermann M, Pixberg MK, Riemann B, et al. Clinical outcomes of adjuvant external-beam radiotherapy for differentiated thyroid cancer: results after 874 patient-years of follow-up in the MSDS-trial. NuklearMedizin. 2009;3:89–98.
   Google Scholar
• Farahati J, Reiners C, Stuschke M, et al. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer. 1996;77(1):557–566.
   Web of Science ®Google Scholar
• Brierley J, Tsang R, Panzarella T, et al. Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years. Clin Endocrinol (Oxf). 2005;63:418–427.
   PubMed Web of Science ®Google Scholar
• Simpson WJ, Carruthers JS. Gospodarowciz. Sutcliffe SB. Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys. 1988;14:1063–1075.
   PubMed Web of Science ®Google Scholar
• Kim TH, Yang DS, Jung KY, et al. Value of external irradiation for locally advanced papillary thyroid cancer. Int J Radiat Oncol Biol Phys. 2003;55(4):1006–1012.
   PubMed Web of Science ®Google Scholar
• Keum KC, Suh YG, Koom WS, et al. The role of postoperative external-beam radiotherapy in the management of patients with papillary thyroid cancer invading the trachea. Int J Radiat Oncol Biol Phys. 2006;65(2):474–480.
   PubMed Web of Science ®Google Scholar
• Hyer SL, Dandekar P, Newbold K, et al. Thyroid cancer causing obstruction of the great veins in the neck. World J Surg Oncol. 2008;6:36. DOI:10.1186/1477-7819-6-36.
   PubMed Web of Science ®Google Scholar
• Marcy PR, Thariat J, Bozec A, et al. Venous obstruction of thyroid malignancy origin : the Antoine Lacassagne Institute experience. World J Surg Oncol. 2009;7:40. DOI:10.1186/1477-7819-7-40.
   Google Scholar
• Chow S-M, Law SCK, Mendenhall WM, et al. Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy. Int J Radiat Oncol Biol Phys. 2002;52(3):784–795.
   PubMed Web of Science ®Google Scholar
• Terezakis SA, Lee KS, Ghossein RA, et al. Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys. 2009;73(3):795–801.
   PubMed Web of Science ®Google Scholar
• Meadows K, Amud R, Morris C, et al. External beam radiotherapy for differentiated thyroid cancer. Am J Otolaryngol. 2006;27:24–28.
   PubMed Web of Science ®Google Scholar
• Tsang R, Brierly J, Simpson W, et al. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer. 1998;82(2):375–388.
   PubMed Web of Science ®Google Scholar
• Kiess AP, Agrawal N, Brierley JD, et al. External-beam radiotherapy for differentiated thyroid cancer locoregional control: A statement of the American Head and Neck Society. Head Neck. 2016;38(4):493–498.
   PubMed Web of Science ®Google Scholar
• Powell C, Newbold K, Harrington KJ, et al. External beam radiotherapy for differentiated thyroid cancer statement of search strategies used and sources of information. Clin Oncol. 2010;22:456–463.
   Web of Science ®Google Scholar
• Marcus C, Whitworth PW, Subramaniam RM, et al. PET/CT in the management of thyroid cancers. 2014;(June):1316–1329. doi:10.2214/AJR.13.11673.
   Google Scholar
• ICRU 62. Prescribing, recording and reporting photon beam therapy. 1999.
   Google Scholar
• Giuliani M, Brierley J. Indications for the use of external beam radiation in thyroid cancer. Curr Opin Oncol. 2014;26:45–50.
   PubMed Web of Science ®Google Scholar
• Kim TH, Chung K-W, Lee YJ, et al. The effect of external beam radiotherapy volume on locoregional control in patients with locoregionally advanced or recurrent nonanaplastic thyroid cancer. Radiat Oncol. 2010;5:69.
   PubMed Web of Science ®Google Scholar
• Azrif M, Slevin NJ, Sykes AJ, et al. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation. Radiother Oncol. 2008;89:105–113.
   PubMed Web of Science ®Google Scholar
• Sun XS, Sun SR, Guevara N, et al. Indications of external beam radiation therapy in non-anaplastic thyroid cancer and impact of innovative radiation techniques. Crit Rev Oncol /Hematol. 2013;86(1):52–68.
   PubMed Web of Science ®Google Scholar
• Schwartz DL, Lobo MJ, Ang KK, et al. Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment. Int J Radiat Oncol Biol Phys. 2009;74(4):1083–1091.
   PubMed Web of Science ®Google Scholar
• Nutting CM, Convery DJ, Cosgrove VP, et al. Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland. Radiother Oncol. 2001;60(2):173–180.
   PubMed Web of Science ®Google Scholar
• Schuck A, Biermann M, Pixberg MK, et al. Acute toxicity of adjuvant radiotherapy in locally advanced differentiated thyroid carcinoma. Strahlentherapie Und Onkol. 2003;179(12):832–839.
   PubMed Web of Science ®Google Scholar
• Phlips P, Hanzen C, Andry G, et al. Postoperative irradiation for thyroid cancer. Eur J Surg Oncol. 1993;19(5):399–404.
   PubMedGoogle Scholar
• Gal TJ, Streeter M, Burris J, et al. Quality of life impact of external beam radiotherapy for advanced thyroid carcinoma. Thyroid. 2013;23(1):64–69.
   PubMed Web of Science ®Google Scholar
• Proye CAG, Dromer DHR, Carnaille BM, et al. Is it still worthwhile to treat bone metastases from differentiated thyroid carcinoma with radioactive iodine? World J Surg. 1992;16:640–646.
   PubMed Web of Science ®Google Scholar
• Bonichon F, Buy X, Godbert Y, et al. Local treatment of metastases from differentiated thyroid cancer; Traitement local des métastases de cancer thyroïdien différencié. Annales d’Endocrinologie. 2015;76:1S40–1S46.
   PubMed Web of Science ®Google Scholar
• Bernstein M, Chang E, Amini B. Spine stereotactic radiosurgery for patients with metastatic thyroid cancer: secondary analysis of phase I/II trials. Thyroid. 2016;26(9):1269–1275.
   PubMed Web of Science ®Google Scholar
• Cazzato RL, Bonichon F, Buy X, et al. Over ten years of single-institution experience in percutaneous image-guided treatment of bone metastases from differentiated thyroid cancer. Eur J Surg Oncol. 2015;41(9):1247-1255. DOI:10.1016/j.ejso.2015.06.005.
   PubMed Web of Science ®Google Scholar
• Antonelli A, Fallahi P, Ulisse S, et al. New targeted therapies for thyroid cancer. Current Genomics. 2011;12:626–631.
   PubMed Web of Science ®Google Scholar